FindTrial
Sign In

DIFFERENT REGIMENS FOR ERADICATION OF HELICOBACTER PYLORI INFECTION IN CHILDREN: A RANDOMIZED CONTROLLED TRIAL

DIFFERENT REGIMENS FOR ERADICATION OF HELICOBACTER PYLORI INFECTION IN CHILDREN: A RANDOMIZED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202201686010590
Enrollment
200
Registered
2022-01-04
Start date
2022-01-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Helicobacter pylori

Interventions

Triple therapy
sequential therapy
hybrid therapy
concomitant therapy
ciprofloxacin based triple therapy

Sponsors

Pediatric department Alexandria University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: children suffering of symptoms suggestive of H. pylori infection. gastric biopsy positive for H pyloi infection

Exclusion criteria

Exclusion criteria: History of drug allergy to any of the medications used in the study. Presence of any concurrent illness that prevents the intake of the eradication regimen. The intake of any previous treatment with anti-secretory, antimicrobial or anti-inflammatory medications 4 weeks prior to obtaining the gastric biopsies.

Design outcomes

Primary

MeasureTime frame
fecal H. pylori antigen—

Secondary

MeasureTime frame
Adverse effects of drugs used in the treatment—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 5, 2026